Moderna Stock Falls Following Revenue Outlook Cut Due to UK Vaccine Delay
Moderna Stock took a hit after the company shared its latest earnings and cut its revenue outlook. The biotechnology giant reported weaker than expected results, sending its shares down over 8% on Friday. This drop reflects broader concerns in the stock market about Moderna’s future growth.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
